GlassScriptPhysician profile
Mary P Cheney
NPI 1982719407
$2,409.78
in general payments reported to CMS, 2019-2025
17 companies · $750 in 2025
The $750 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $148 · 2023: $271 · 2024: $997 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599 · Consulting Fee: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.88 |
| Consulting Fee | $420.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $670.05 | 2024-2025 | Tegaderm, Activ.A.C., V.A.C. Veraflo |
| Kerecis Limited | $403.37 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Novo Nordisk INC | $278.60 | 2022-2024 | Wegovy |
| Janssen Pharmaceuticals, INC | $177.88 | 2021-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $128.73 | 2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $123.03 | 2021-2023 | Andexxa |
| Sanofi-Aventis U.S. LLC | $99.19 | 2025 | |
| Organogenesis INC. | $80.39 | 2023-2025 | Apligraf, Puraply |
| Smith+Nephew, INC. | $75.63 | 2021-2024 | Grafix, Oasis, Collagenase Santyl |
| Bayer Healthcare Pharmaceuticals INC. | $70.90 | 2025 | |
| Pfizer INC. | $70.90 | 2025 | |
| Integra Lifesciences Corporation | $64.25 | 2022-2025 | Tcc-Ez |
| Ets Wound Care LLC | $54.72 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Kci USA, INC. | $46.43 | 2021-2023 | Snap |
| Mimedx Group, INC. | $25.47 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $25.00 | 2025 | Nuzyra |
| Hydrofera LLC | $15.24 | 2024 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cheney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.